Ipamorelin vs Sermorelin: GH Secretagogue Comparison
Ipamorelin
GH SecretagogueIpamorelin is a selective growth hormone (GH) secretagogue and ghrelin mimetic. It stimulates the pituitary gland to release growth hormone in a pulsatile pattern that mimics natural GH secretion.
View full profile →Sermorelin
GH SecretagogueSermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It was the first GHRH analogue approved by the FDA for treating GH deficiency in children.
View full profile →Comparison Overview
Ipamorelin and Sermorelin are both growth hormone secretagogues, but they stimulate GH release through entirely different receptor pathways. Ipamorelin is a ghrelin mimetic that binds to the GHSR (growth hormone secretagogue receptor) in the pituitary, while Sermorelin is a GHRH analogue that binds to growth hormone-releasing hormone receptors. This fundamental difference has significant implications for their effects and side effect profiles.
One of Ipamorelin's key advantages in research is its selectivity—it stimulates GH release without significantly affecting cortisol or prolactin levels, which is uncommon among GHRPs. Sermorelin, as the first 29 amino acids of natural GHRH, works through the body's existing feedback mechanisms, which may help preserve pituitary function over long-term use. Sermorelin also has a historical advantage: it was the first GHRH analogue to receive FDA approval for pediatric GH deficiency.
Both peptides produce pulsatile GH release that more closely mimics natural physiology compared to direct GH administration. Researchers frequently study both individually and as part of combination protocols with other GH-related peptides.
Key Differences
| Category | Ipamorelin | Sermorelin |
|---|---|---|
| Mechanism Type | Ghrelin mimetic (binds GHSR receptor) | GHRH analogue (binds GHRH receptor) |
| Selectivity | Highly selective—minimal cortisol/prolactin impact | Works through natural GHRH pathway with normal feedback |
| FDA History | No FDA approval history | Previously FDA-approved for pediatric GH deficiency |
| Half-Life | Approximately 2 hours | Approximately 10-20 minutes |
| GH Pulse Pattern | Strong, selective GH pulse | Natural-pattern GH release with feedback preservation |
| Common Stacking | Frequently studied with CJC-1295 (Mod GRF 1-29) | Often studied as a standalone or with GHRP peptides |
Overlapping Research Areas
- GH optimization
- Anti-aging research
- Sleep improvement
- Body composition studies
- Recovery enhancement
Which One to Research?
Ipamorelin is often preferred in research settings where selectivity matters—particularly when avoiding cortisol and prolactin elevation is important. Sermorelin may appeal to researchers interested in a more physiologically natural GHRH pathway with built-in feedback mechanisms. Ipamorelin is frequently paired with CJC-1295 for enhanced GH release, while Sermorelin is commonly studied as a standalone secretagogue.
⚠️ Important: This comparison is for informational and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any decisions regarding peptide use.
Learn More in the Peptide Playbook
Get comprehensive protocols, dosing information, and vendor selection guidance.
Get the Full Guide →